| Primary |
| Hiv Infection |
52.9% |
| Product Used For Unknown Indication |
25.5% |
| Maternal Exposure Timing Unspecified |
10.6% |
| Prophylaxis |
1.9% |
| Urinary Tract Infection |
1.9% |
| Malaria Prophylaxis |
1.4% |
| Hypertension |
1.0% |
| Pulmonary Tuberculosis |
1.0% |
| Renal Failure |
1.0% |
| Vitamin Supplementation |
1.0% |
| Antifungal Prophylaxis |
0.5% |
| Antiretroviral Therapy |
0.5% |
| Mineral Supplementation |
0.5% |
| Vulvovaginal Candidiasis |
0.5% |
|
| Abortion Induced |
19.6% |
| Abortion Spontaneous |
8.7% |
| Premature Baby |
8.7% |
| Stillbirth |
8.7% |
| Anaemia |
6.5% |
| Death |
6.5% |
| Sepsis |
6.5% |
| Foetal Death |
4.3% |
| Intestinal Obstruction |
4.3% |
| Pelvic Mass |
4.3% |
| Abortion Missed |
2.2% |
| Blighted Ovum |
2.2% |
| Cardiac Failure Congestive |
2.2% |
| Malignant Hypertension |
2.2% |
| Mania |
2.2% |
| Neonatal Asphyxia |
2.2% |
| Nervous System Disorder |
2.2% |
| Neutropenia |
2.2% |
| Normal Newborn |
2.2% |
| Ovarian Neoplasm |
2.2% |
|
| Secondary |
| Hiv Infection |
69.9% |
| Product Used For Unknown Indication |
7.1% |
| Antiretroviral Therapy |
4.5% |
| Acquired Immunodeficiency Syndrome |
3.8% |
| Maternal Exposure Timing Unspecified |
3.2% |
| Bacterial Infection |
2.6% |
| Nausea |
2.6% |
| Prophylaxis |
2.6% |
| Malaria Prophylaxis |
1.9% |
| Pain |
1.3% |
| Osteoporosis |
0.6% |
|
| Abortion Spontaneous |
11.9% |
| Vomiting |
11.9% |
| Stillbirth |
9.5% |
| Anaemia |
7.1% |
| Mental Disorder Due To A General Medical Condition |
7.1% |
| Pregnancy |
7.1% |
| Renal Failure |
7.1% |
| Death |
4.8% |
| Gastritis |
4.8% |
| Renal Dysplasia |
4.8% |
| Abortion |
2.4% |
| Abortion Incomplete |
2.4% |
| Disseminated Tuberculosis |
2.4% |
| Dizziness |
2.4% |
| Gastroenteritis |
2.4% |
| Hepatic Encephalopathy |
2.4% |
| Hepatic Failure |
2.4% |
| Hepatitis Acute |
2.4% |
| Hypertriglyceridaemia |
2.4% |
| Hypothermia |
2.4% |
|
| Concomitant |
| Hiv Infection |
58.5% |
| Antiviral Treatment |
28.5% |
| Prophylaxis |
3.8% |
| Opportunistic Infection Prophylaxis |
3.1% |
| Acquired Immunodeficiency Syndrome |
1.5% |
| Pain |
1.5% |
| Antiretroviral Therapy |
0.8% |
| Malaria |
0.8% |
| Opportunistic Infection |
0.8% |
| Osteoporosis |
0.8% |
|
| Abortion Spontaneous |
33.3% |
| Peptic Ulcer |
11.1% |
| Stillbirth |
11.1% |
| Abortion Induced |
8.9% |
| Ventricular Septal Defect |
6.7% |
| Hepatotoxicity |
4.4% |
| Renal Disorder |
4.4% |
| Angioedema |
2.2% |
| Blood Lactic Acid Increased |
2.2% |
| Congenital Central Nervous System Anomaly |
2.2% |
| Foetal Exposure During Pregnancy |
2.2% |
| Osteonecrosis |
2.2% |
| Pregnancy |
2.2% |
| Renal Failure |
2.2% |
| Upper Respiratory Tract Infection |
2.2% |
| Weight Decreased |
2.2% |
|
